IPO Letter to U.S. Senate Opposing S. 2658, the Medication Affordability and Patent Integrity Act
IPO Letter to U.S. Senate Opposing S. 2658, the Medication [...]
Letter to U.S. House Committee on the Judiciary Regarding Hearing on the ETHIC Act and Skinny Labels, Big Savings Act
Letter to U.S. House Committee on the Judiciary Regarding Hearing [...]
IPO’s Notice of Intent to Testify and Hearing Statement re: 2026 Special 301
IPO’s Notice of Intent to Testify and Hearing Statement re: [...]
IPO 2026 Special 301 Comments
IPO 2026 Special 301 Comments
IPO Comments to UKIPO in Response to the Consultation on Changes to the UK Designs Framework
IPO Comments to UKIPO in Response to the Consultation on [...]
IPO Comments to OSTP on Regulatory Reform on Artificial Intelligence
IPO Comments to OSTP on Regulatory Reform on Artificial Intelligence
IPO Comments to INPI Regarding Draft Guidelines for Patent Examination of AI-Related Inventions
IPO Comments to INPI Regarding Draft Guidelines for Patent Examination [...]
IPO Comments to USTR Regarding 2025 Notorious Markets
IPO Comments to USTR Regarding 2025 Notorious Markets
IPO Comments to USPTO Regarding OECD Draft Voluntary Guidelines for Countering Illicit Trade in Counterfeit Goods on Online Marketplaces
IPO Comments to USPTO Regarding OECD Draft Voluntary Guidelines for [...]
IPO Request to Testify and Hearing Statement re: World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge
IPO Request to Testify and Hearing Statement re: World Intellectual [...]